The Dural Graft Market is bound to witness a CAGR of 6% and US$ 1.1 Bn between 2019-2029. The current scenario is such that technology is making inroads into the healthcare vertical, which is, in turn, reducing the cumbersome, in-person interactions with the caregiver. Telehealth is expected to outlive physical meetings in the forecast period. This would be the state of the healthcare vertical going forward.
Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products. Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products. For instance, in 2004, the World Health Organization (WHO) estimated that, there were 33,193 neurosurgeons worldwide, including trainees. Whereas, in 2015, this number rose to approximately 49,940 neurosurgeons, with a 4% total growth, worldwide.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25285
Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).
Company Profiles:
- Cook Medical.
- Integra Lifesciences Corporation
- B Braun
- Cousin Biotech,
- Natus Medical Incorporated
- Tissuemed Ltd,
- Vostra GmbH
- Stryker Corporation
- Medtronic Plc.
- Johnson & Johnson,
- Aesculap, Inc.
- Baxter International Inc
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25285
Key Takeaways of Dural Graft Market Study
- By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
- Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
- Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
- Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
- Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
- Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.
“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/25285
Brain and Spinal Tumor Application Dominating Dural Graft Market
Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes. For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.
About us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com